Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2013-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/jth.12247PMID 23809128PMCID PMC3713536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma.

  2012cited by this paper
• Diversity and modularity of G protein-coupled receptor structures.

  2012cited by this paper
• Is EPCR a multi-ligand receptor? Pros and cons

  2012cited by this paper
• Targeting proteinase-activated receptors: therapeutic potential and challenges

  2012cited by this paper
• Pharmacological targeting of the thrombomodulin–protein C pathway mitigates radiation toxicity

  2012cited by this paper
• A new era of GPCR structural and chemical biology.

  2012cited by this paper
• sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove.

  2012cited by this paper
• The protein C pathway in cancer metastasis.

  2012cited by this paper
• Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.

  2012cited by this paper
• Biased Signaling Pathways in β2-Adrenergic Receptor Characterized by 19F-NMR

  2012cited by this paper
• Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes.

  2012cited by this paper
• The best of both worlds? Bitopic orthosteric/allosteric ligands of g protein-coupled receptors.

  2012cited by this paper
• Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.

  2012cited by this paper
• Drotrecogin alfa (activated) in adults with septic shock.

  2012cited by this paper
• Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor

  2012cited by this paper
• The occupancy of endothelial protein C receptor by its ligand modulates the par‐1 dependent signaling specificity of coagulation proteases

  2011cited by this paper
• Protease activated receptor-2 mediates activated protein C-induced cutaneous wound healing via inhibition of p38.

  2011cited by this paper
• The structure-function relationship of activated protein C

  2011cited by this paper
• Multiple receptor-mediated functions of activated protein C

  2011cited by this paper
• Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protection.

  2011cited by this paper
• Factor X binding to endothelial cell protein C receptor: comparison with factor VIIa and activated protein C.

  2011cited by this paper
• Protein C anticoagulant system—anti-inflammatory effects

  2011cited by this paper
• Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.

  2011cited by this paper
• Cytoprotective protein C pathways and implications for stroke and neurological disorders.

  2011cited by this paper
• Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds

  2011cited by this paper
• The anticoagulant function of coagulation factor V

  2011cited by this paper
• Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice.

  2011cited by this paper
• The Endothelial Protein C Receptor Supports Tissue Factor Ternary Coagulation Initiation Complex Signaling through Protease-activated Receptors*

  2010cited by this paper
• Bio‐distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)

  2010cited by this paper
• Coagulation factor Xa cleaves protease‐activated receptor‐1 and mediates signaling dependent on binding to the endothelial protein C receptor

  2010cited by this paper
• The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

  2010cited by this paper
• Regulation of the protein C anticoagulant and antiinflammatory pathways.

  2010cited by this paper
• Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function

  2010cited by this paper
• Thrombin upregulates the angiopoietin–Tie2 Axis: endothelial protein C receptor occupancy prevents the thrombin mobilization of angiopoietin 2 and P‐selectin from Weibel–Palade bodies

  2010cited by this paper
• Regulation of inflammation by the protein C system

  2010cited by this paper
• Phospholipase A2s: developing drug targets for atherosclerosis.

  2010cited by this paper
• The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.

  2010cited by this paper
• Lipoprotein-Associated and Secreted Phospholipases A2 in Cardiovascular Disease: Roles as Biological Effectors and Biomarkers

  2010cited by this paper
• APC resistance: biological basis and acquired influences

  2010cited by this paper
• The role of dynamic conformational ensembles in biomolecular recognition.

  2009cited by this paper
• Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant.

  2009cited by this paper
• Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways.

  2009cited by this paper
• Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis.

  2009cited by this paper
• Caveolae are required for protease-selective signaling by protease-activated receptor–1

  2009cited by this paper
• Extracellular histones are major mediators of death in sepsis

  2009cited by this paper
• Role of activated protein C and its receptor in inhibition of tumor metastasis.

  2009cited by this paper
• Endothelial Protein C Receptor-Assisted Transport of Activated Protein C across the Mouse Blood—Brain Barrier

  2009cited by this paper
• Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement.

  2009cited by this paper
• Proteases display biased agonism at protease-activated receptors: location matters!

  2009cited by this paper
• Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells

  2009cited by this paper
• Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin.

  2008cited by this paper
• Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement*

  2008cited by this paper
• Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1.

  2008cited by this paper
• Detailed Mechanisms of the Inactivation of Factor VIIIa by Activated Protein C in the Presence of Its Cofactors, Protein S and Factor V*

  2008cited by this paper
• Regulation of Endothelial Junctional Permeability

  2008cited by this paper
• Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells

  2008cited by this paper
• Endothelial cell protein C receptor cellular localization and trafficking: potential functional implications.

  2008cited by this paper
• Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein C

  2007cited by this paper
• Identification of a Specific Exosite on Activated Protein C for Interaction with Protease-activated Receptor 1*

  2007cited by this paper
• Engineering a Disulfide Bond to Stabilize the Calcium-binding Loop of Activated Protein C Eliminates Its Anticoagulant but Not Its Protective Signaling Properties*

  2007cited by this paper
• Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1.

  2007cited by this paper
• Dual Regulation of Endothelial Junctional Permeability

  2007cited by this paper
• Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis

  2007cited by this paper
• 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage

  2007cited by this paper
• The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells.

  2007cited by this paper
• Regulated endothelial protein C receptor shedding is mediated by tumor necrosis factor‐α converting enzyme/ADAM17

  2007cited by this paper
• Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells

  2007cited by this paper
• Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization

  2007cited by this paper
• Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity

  2007cited by this paper
• Protein C and its inhibitor in malignancy.

  2007cited by this paper
• Endothelial Cell Protein C Receptor Acts as a Cellular Receptor for Factor VIIa on Endothelium*

  2007cited by this paper
• bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. The cytoprotective protein C pathway

  2006cited by this paper
• Roles of protease-activated receptors in a mouse model of endotoxemia.

  2006cited by this paper
• Protease‐activated receptors in hemostasis, thrombosis and vascular biology

  2005cited by this paper
• Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement

  2005cited by this paper
• Protease-activated Receptor-1 Signaling by Activated Protein C in Cytokine-perturbed Endothelial Cells Is Distinct from Thrombin Signaling*

  2005cited by this paper
• Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin

  2005cited by this paper
• Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway: Novel Insights Into Structure–Function Relationships and Molecular Recognition

  2005cited by this paper
• Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.

  2005cited by this paper
• Activated protein C variants with normal cytoprotective but reduced anticoagulant activity.

  2004cited by this paper
• Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3.

  2004cited by this paper
• Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation

  2004cited by this paper
• The discovery of thrombomodulin

  2004cited by this paper
• Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.

  2004cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis

  2003cited by this paper
• Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway

  2002cited by this paper
• The Crystal Structure of the Endothelial Protein C Receptor and a Bound Phospholipid*

  2002cited by this paper
• Expression of the vascular endothelial cell protein C receptor in epithelial tumour cells.

  2002cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis*

  2001cited by this paper
• Expression and Anticoagulant Function of the Endothelial Cell Protein C Receptor (EPCR) in Cancer Cell Lines

  2001cited by this paper
• Thrombin signalling and protease-activated receptors

  2000cited by this paper
• The Endothelial Cell Protein C Receptor

  2000cited by this paper
• Thrombin Responses in Human Endothelial Cells

  2000cited by this paper
• Exclusion of Known Protease Activated Receptors in Factor VIIa-induced Signal Transduction

  2000cited by this paper
• Metalloproteolytic Release of Endothelial Cell Protein C Receptor*

  2000cited by this paper
• Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo.

  2000cited by this paper
• Regulation of factor VIIIa by human activated protein C and protein S: inactivation of cofactor in the intrinsic factor Xase.

  2000cited by this paper
• Mechanisms by Which Soluble Endothelial Cell Protein C Receptor Modulates Protein C and Activated Protein C Function*

  2000cited by this paper
• Relocating the Active Site of Activated Protein C Eliminates the Need for Its Protein S Cofactor

  1999cited by this paper

• Revisiting antiphospholipid syndrome: A thrombo-inflammatory disorder beyond clotting.

  2026cites this paper
• Seaweed-derived bioactives and nutrition: Emerging functional strategies for cardiovascular disease prevention

  2026cites this paper
• A mini review on the regulation of coagulation homeostasis through interfering with vitamin K-dependent coagulation/anticoagulation factors.

  2025cites this paper
• Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis

  2025cites this paper
• Protease engineering: Approaches, tools, and emerging trends.

  2025cites this paper
• The predictive value of inflammatory biomarkers for arteriovenous fistula failure: A systematic review and meta-analysis

  2025cites this paper
• Pattern recognition receptor-associated immuno-thrombotic transcript changes in platelets and leukocytes with COVID19

  2025cites this paper
• Stochastic resonance represents one of the mechanisms that trigger protein ligand unbinding.

  2025cites this paper
• Anti-EPCR autoantibodies in ulcerative colitis show sex- and lipid-dependent patterns

  2025cites this paper
• Genetic determinants of activated factor VII-antithrombin plasma levels and mortality in patients with coronary artery disease.

  2025cites this paper
• Construction of a Producer Strain of the Fibrinolitic Enzyme PAPC Based on Pichia pastoris Yeast

  2025cites this paper
• Research into New Molecular Mechanisms in Thrombotic Diseases Paves the Way for Innovative Therapeutic Approaches

  2024cites this paper
• Heme induced loss of renovascular endothelial protein C receptor promotes chronic kidney disease in sickle mice.

  2024cites this paper
• Natural Anticoagulant Protein Levels in Patients With Beta-Thalassemia Major: A Case-Control Study

  2024cites this paper
• Targeting mono- and dual-species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa by the recombinant anticoagulant enzyme PAPC from micromycete Aspergillus ochraceus.

  2024cites this paper
• Dysregulated Coagulation and Fibrinolysis Are Present in Patients Admitted to the Emergency Department with Acute Hypoxemic Respiratory Failure: A Prospective Study

  2024cites this paper
• A Novel Murine Model Enabling rAAV8-PC Gene Therapy for Severe Protein C Deficiency

  2024cites this paper
• Cutting edge of immune response and immunosuppressants in allogeneic and xenogeneic islet transplantation

  2024cites this paper
• Effect of prior anticoagulation therapy on outcomes of traumatic brain injury: A systematic review and meta‑analysis

  2024cites this paper
• Endothelial Protein C Receptor and Its Impact on Rheumatic Disease

  2024cites this paper
• Cytoprotective E-WE thrombin reduces disease severity in a murine model of relapsing-remitting multiple sclerosis.

  2023cites this paper
• E-WE thrombin, a protein C activator, reduces disease severity and spinal cord inflammation in relapsing-remitting murine experimental autoimmune encephalomyelitis

  2023cites this paper
• Mitigation of trauma-induced endotheliopathy by activated protein C: A potential therapeutic for postinjury thromboinflammation

  2023cites this paper
• Unraveling the Molecular Mechanisms of Activated Protein C (APC) in Mitigating Reperfusion Injury and Cardiac Ischemia: a Promising Avenue for Novel Therapeutic Interventions

  2023cites this paper
• Therapeutic management of ischemic stroke

  2023cites this paper
• Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus

  2022cites this paper
• Significance of the multifunctional protein C system research in the treatment of patients with indirect anticoagulants (literature review)

  2022cites this paper
• The Association between Protein C and Antithrombin III Levels with the Severity of Coronavirus Disease-2019 Symptoms

  2022cites this paper
• Host-directed therapies for malaria: possible applications and lessons from other indications.

  2022cites this paper
• Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations

  2022cites this paper
• Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis—From Pathophysiology to Therapeutic Implications

  2022cites this paper
• Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus

  2022cites this paper
• Investigations of the effectiveness of heparin variants as inhibitors of histones

  2022cites this paper
• CircRNA–miRNA interactions in atherogenesis

  2022cites this paper
• Postinjury complement C4 activation is associated with adverse outcomes and is potentially influenced by plasma resuscitation

  2022cites this paper
• "Activated Protein C (APC) Promotes A Healing Phenotype in Cultured Murine Tenocytes Via Protease- Activated Receptor (PAR)-2, but not PAR-1"

  2021cites this paper
• Comparison of Acquired Activated Protein C Resistance, Using the CAT and ST-Genesia® Analysers and Three Thrombin Generation Methods, in APS and SLE Patients

  2021cites this paper
• Gene Analysis, Cloning, and Heterologous Expression of Protease from a Micromycete Aspergillus ochraceus Capable of Activating Protein C of Blood Plasma

  2021cites this paper
• Borrelia burgdorferi infection modifies protein content in saliva of Ixodes scapularis nymphs

  2021cites this paper
• Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence

  2021cites this paper
• Increased expression of Protein S in eyes with diabetic retinopathy and diabetic macular edema

  2021cites this paper
• Immunogenetics of xenotransplantation

  2021cites this paper
• Sex-dependent effects of genetic upregulation of activated protein C on delayed effects of acute radiation exposure in the mouse heart, small intestine, and skin

  2021cites this paper
• Sickle-trait hemoglobin reduces adhesion to both CD36 and EPCR by Plasmodium falciparum-infected erythrocytes

  2021cites this paper
• Effect of Immobilization of the Micromycete Aspergillus ochraceus VKM-F4104D in Polymeric Carriers on the Production of the Fibrinolytic Protease Activator of Blood Plasma Protein C

  2021cites this paper
• aPC/PAR1 confers endothelial anti-apoptotic activity via a discrete β-arrestin-2 mediated SphK1-S1PR1-Akt signaling axis

  2021cites this paper
• INDEPENDENT PREDICTORS AND PROGNOSIS OF LONG-TERM MYOCARDIAL INFARCTION IN PATIENTS WITH UNSTABLE ANGINA AFTER CORONARY ARTERY STENTING

  2021cites this paper
• Protease‐activated receptor signaling in intestinal permeability regulation

  2020cites this paper
• Comparison of Protein-C levels in type 2 Diabetes Mellitus patients with and without diabetic foot ulcers at Haji Adam Malik Hospital, Medan, Indonesia from May to July 2017

  2020cites this paper
• Neuroprotective Effects of Activated Protein C Involve the PARP/AIF Pathway against Oxygen-Glucose Deprivation in SH-SY5Y Cells

  2020cites this paper
• Defining and Assessing the Endotheliopathy of Trauma and Its Implications on Trauma-Induced Coagulopathy and Trauma-Related Outcomes

  2020cites this paper
• Impact of Acute and Chronic Stress on Thrombosis in Healthy Individuals and Cardiovascular Disease Patients

  2020cites this paper
• Severe Protein C Deficiency due to Novel Biallelic Variants in PROC and Their Phenotype Correlation

  2020cites this paper
• Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?

  2020cites this paper
• X chromosome-dependent disruption of placental regulatory networks in hybrid dwarf hamsters

  2020cites this paper
• Revisiting the Protein C Pathway: An Opportunity for Adjunctive Intervention in COVID-19?

  2020cites this paper
• Elucidating mechanisms of genetic cross-disease associations: an integrative approach implicates protein C as a causal pathway in arterial and venous diseases

  2020cites this paper
• Immunization with virus-like particles conjugated to CIDRα1 domain of Plasmodium falciparum erythrocyte membrane protein 1 induces inhibitory antibodies

  2020cites this paper
• Purification of the Protease Activator of Protein C of Human Blood Plasma Produced by the Micromycete Aspergillus ochraceus VKM F-4104D

  2020cites this paper
• Xenotransplantation 1.0 to 2.0

  2020cites this paper
• Re-Evaluating Biologic Pharmacotherapies That Target the Host Response during Sepsis

  2019cites this paper
• Blood coagulation parameters in rats with acute radiation syndrome receiving activated carbon as a preventive remedy

  2019cites this paper
• Plasma From Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble Thrombomodulin

  2019cites this paper
• Expression Characteristics of Genes Hypermethylated and Downregulated in Rat Liver Specific to Nongenotoxic Hepatocarcinogens

  2019cites this paper
• Activated Protein C in Cutaneous Wound Healing: From Bench to Bedside

  2019cites this paper
• The bacterial protein CNF1 as a new strategy against Plasmodium falciparum cytoadherence

  2019cites this paper
• Comment on “Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination” Cancers 2019, 11, 51

  2019cites this paper
• The parmodulin NRD-21 is an allosteric inhibitor of PAR1 Gq signaling with improved anti-inflammatory activity and stability.

  2019cites this paper
• Laboratory Evaluation of Hemostasis Disorders

  2019cites this paper
• A Review of Recent Patents Regarding Antithrombotic Drugs Derived From Natural Products

  2019cites this paper
• Activated protein C induces suppression and regression of choroidal neovascularization- A murine model.

  2019cites this paper
• Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers but not of Prothrombin 20210G>A Carriers.

  2019cites this paper
• University of Groningen Plasma from Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble Thrombomodulin (ART-123) Burlage,

  2019cites this paper
• APC ameliorates pulmonary complications in cGVHD.

  2019cites this paper
• Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1‐based vaccines to prevent it

  2019cites this paper
• Clinical Impact of Coagulation and Fibrinolysis Markers for Predicting Postoperative Venous Thromboembolism in Total Joint Arthroplasty Patients

  2019cites this paper
• Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour.

  2019cites this paper
• Design and Evaluation of Heterobivalent PAR1-PAR2 Ligands as Antagonists of Calcium Mobilization.

  2018cites this paper
• Chapter 1 Hemostatic System in Malignancy : Providing the “ Soil ” in Metastatic Niche Formation

  2018cites this paper
• Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells

  2018cites this paper
• Blood coagulation and aortic wall integrity in rats with obesity-induced insulin resistance

  2018cites this paper
• The evolution of activated protein C plasma levels in septic shock and its association with mortality: A prospective observational study☆

  2018cites this paper
• Protease‐activated receptor‐1 impedes prostate and intestinal tumor progression in mice

  2018cites this paper
• Lower plasma protein C activity is associated with early myocardial necrosis and no-reflow phenomenon in patients with ST elevation myocardial infarction

  2018cites this paper
• Biology of Coagulation and Coagulopathy in Neurologic Surgery.

  2018cites this paper
• PAR-1 is a novel mechano-sensor transducing laminar flow-mediated endothelial signaling

  2018cites this paper
• Under crossfire: thromboembolic risk in systemic lupus erythematosus.

  2018cites this paper
• Role of Endothelial Cells in Acute and Chronic Thrombosis

  2018cites this paper
• Effets anti-inflammatoires de l'inhibiteur dépendant de la protéine Z : intérêt potentiel comme traitement adjuvant du sepsis. (Anti-inflammatory effects of Protein Z-dependent protease inhibitor (ZPI) : potential benefit on sepsis adjuvant therapy)

  2018cites this paper
• An ADAM-10 dependent EPCR shedding links meningococcal interaction with endothelial cells to purpura fulminans

  2018cites this paper
• Endothelial cell protein C receptor-dependent signaling

  2018cites this paper
• Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells.

  2018cites this paper
• Determinants and modifiers of bleeding phenotypes in haemophilia-A: General and tropical perspectives

  2018influential citation
• Systemic sclerosis

  2018cites this paper
• PLATELETS, NEUTROPHILS, AND FXII IN SPONTANEOUS VENOUS THROMBOSIS

  2018cites this paper
• A preliminary estimation of tissue factor pathway inhibitor (TFPI) and protein C in patients with intracranial tumors.

  2017cites this paper
• A new concept of action of hemostatic proteases on inflammation, neurotoxicity, and tissue regeneration

  2017cites this paper
• Decreased Activity of the Protein C Anticoagulant Pathway in the Early Hours of Paroxysmal Atrial Fibrillation

  2017cites this paper
• Coagulation factor and protease pathways in thrombosis and cardiovascular disease

  2017cites this paper
• Mechanisms of Antiphospholipid Antibody-Mediated Thrombosis

  2017cites this paper